If you are going to se Dr Koos could you inquire about the other 2 companies? what his plans are and what he plans on doing with them? It doesn't make sense to me to have a parent company weaker than it's "offspring" Does he plan on using outside funding for a share buyback or a 1 to (lets say 3 or 5) RS to increase the PPS just prior to FDA news from either Hema or Dcell? Is ENTB a wayward child or is it a sleeping giant? I've watched my 1% stake in ENTB be diluted into almost half that. Will my faith be rewarded? Please PM me with some non-SEC 'insider trading info" Regards..... NoQuarter
News 
Market Data 
Discover 
